ChrysCapital announces investment in Corona Remedies
By IANS |
Published on
Mon, Apr 5 2021 20:57 IST |
9 Views
CFMA sees poetic justice for MF investors through 6 FTMF shut funds case in SC.. Image Source: IANS News
New Delhi, April 5 : ChrysCapital, one of the leading private equity funds in India, has announced its investment in Corona Remedies Private Limited (Corona), one of the country s fastest growing pharmaceutical companies, by acquiring a 27 per cent stake through an entirely secondary deal.
Commenting on the investment, Kshitij Sheth, Director, ChrysCapital, said, ChrysCapital is very excited to partner with Corona in its growth journey. The domestic pharmaceutical market is a large, attractive and resilient market with a healthy outlook. Corona is among the fastest growing companies in the Indian pharmaceutical market with presence in exciting therapeutic areas including cardiology, diabetology and gynaecology. ChrysCapital believes Corona
ChrysCap to buy 30% in Corona Remedies for Rs 670 crore
SECTIONS
Share
Synopsis
ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days.
Reuters
Homegrown private equity fund ChrysCapital will invest about Rs 670 crore ($90 million) to acquire about 30% stake in Ahmedabad-based drug manufacturer Corona Remedies.
ChrysCap has signed a deal to acquire 20% stake from PE firm Creador, which is an existing investor, and another 10% from promoters, two people aware of the development said. The announcement is due in a couple of days.